Boardroom Alpha
Boardroom Alpha
DHC · Additional Proxy Materials (DEFA14A) · Filed March 19, 2026

Diversified Healthcare Trust — Additional Proxy Materials (DEFA14A)

Form
DEFA14A
Filed
March 19, 2026
Ticker
DHC
Accession
0001104659-26-032084
Boardroom Alpha · Filing insights

Diversified Healthcare Trust's board urges shareholders to vote FOR all trustee nominees and for auditor ratification.

About Diversified Healthcare Trust
Market cap
$2.1B
1Y TSR
+147.6%
3Y TSR
+58.9%
Board grade
B-
Sector
Real Estate
CEO
Christopher J Bilotto
Last annual meeting: Jun 10, 2026 · View full Diversified Healthcare Trust profile →

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

SCHEDULE 14A

 

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934 (Amendment No. )

 

  Filed by the Registrant Filed by a Party other than the Registrant  

     
Check the appropriate box:
  Preliminary Proxy Statement
  CONFIDENTIAL, FOR USE OF THE COMMISSION ONLY (AS PERMITTED BY RULE 14a-6(e)(2))
  Definitive Proxy Statement
  Definitive Additional Materials
  Soliciting Material under §.240.14a-12
       

Diversified Healthcare Trust

(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

 

Payment of Filing Fee (Check the appropriate box):
No fee required.
Fee paid previously with preliminary materials.
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

 

 

 

 

GRAPHIC

Your Vote Counts! *Please check the meeting materials for any special requirements for meeting attendance. Smartphone users Point your camera here and vote without entering a control number For complete information and to vote, visit www.ProxyVote.com Control # V85431-P48243 You invested in DIVERSIFIED HEALTHCARE TRUST and it’s time to vote! You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy materials for the shareholder meeting to be held on June 10, 2026. Get informed before you vote View the Notice of Annual Meeting, Annual Report and Proxy Statement online OR you can receive a free paper or email copy of the material(s) by requesting prior to May 27, 2026. If you would like to request a copy of the material(s) for this and/or future shareholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy. Vote Virtually at the Meeting* June 10, 2026 9:30 a.m., Eastern Time Virtually at: https://www.virtualshareholdermeeting.com/DHC2026 INVESTOR RELATIONS DIVERSIFIED HEALTHCARE TRUST 255 WASHINGTON STREET, SUITE 300 NEWTON, MASSACHUSETTS 02458 DIVERSIFIED HEALTHCARE TRUST 2026 Annual Meeting Vote by June 9, 2026 11:59 PM ET

GRAPHIC

Vote at www.ProxyVote.com Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”. Voting Items Board Recommends V85432-P48243 THIS IS NOT A VOTABLE BALLOT This is an overview of the proposals being presented at the upcoming shareholder meeting. Please follow the instructions on the reverse side to vote on these important matters. 1. Election of Trustees. For All Nominees (for Independent Trustee): 01) Alan Felder 02) Lisa Harris Jones 03) Phyllis M. Hollis 04) Dawn K. Neher 05) Jeffrey P. Somers Nominees (for Managing Trustee): 06) Christopher J. Bilotto 07) Adam Portnoy 2. Advisory vote to approve executive compensation. For 3. Ratification of the appointment of Deloitte & Touche LLP as independent auditors to serve for the 2026 fiscal year. For

From this filing to the vote

Forecast every director vote the day the proxy files.

Meeting Forecast scores each director up for re-election + every contested situation, rebuilt daily across 6,000+ U.S. public companies. The same model that called the LULU contested proxy lives on every meeting you see here.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Diversified Healthcare Trust (DHC)

Reference

Frequently asked questions

When did Diversified Healthcare Trust file this DEFA14A?
Diversified Healthcare Trust (DHC) filed this Additional Proxy Materials (DEFA14A) with the SEC on March 19, 2026. The accession number assigned by EDGAR is 0001104659-26-032084.
What does a DEFA14A disclose?
DEFA14A is additional definitive proxy soliciting material filed in connection with a shareholder meeting — supplemental letters, slides, or amendments issued after the main proxy statement.
What is the key takeaway from this filing?
Diversified Healthcare Trust's board urges shareholders to vote FOR all trustee nominees and for auditor ratification. This is Boardroom Alpha's one-line summary of the additional proxy materials; see the full filing text above for the formal disclosure.
Where can I find Diversified Healthcare Trust's prior proxy statements on EDGAR?
The SEC EDGAR browser lists every DEFA14A Diversified Healthcare Trust has filed under CIK 1075415, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer